Becton Dickinson plans to pay $4.2 billion for Edwards Lifesciences’ critical care business, which sells technology that monitors the heart conditions of critically ill patients. Edwards had told ...
Edwards Lifesciences Corp. said it’s fighting a $40.1 million punitive damage award stemming from a product liability lawsuit. The Irvine device maker has asked the Washington State Court of Appeals ...
Edwards Lifesciences Corp. recently received FDA clearance for its ForeSight tissue oximetry device, its latest noninvasive medical device capable of measuring the oxygenation of brain tissue. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results